SynthesisFrontiers in microbiology2025
Global research landscape of HIV and Kaposi's sarcoma: a visualized bibliometric analysis.
Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human immunodeficiency virus (HIV) infection remains a significant global health challenge, with Kaposi's sarcoma (KS) being one of the most common AIDS-defining cancers. This study aimed to investigate the development of HIV and KS (HIV-KS) research through bibliometric analysis and to assess the current literature to advance the field. Methods: We gathered 1,568 publications on HIV-KS from the Web of Science Core Collection and analyzed them to visualize the data, identifying future directions and emerging trends by CiteSpace software. Betweenness centrality, count, and burst value were used as metrics. Results: The number of publications on HIV-KS fluctuated in the included literature. The most important contributions from countries and institutions were the United States and the National Institutes of Health (NIH) - USA, respectively. Denise Whitby was the most prolific author, while Yuan Chang had the highest cocitation count. The most commonly cited article is "Kaposi sarcoma (2019)." The hotspots in this field are "basic mechanism," "Kaposi's sarcoma-associated herpesvirus-related disease," and "treatment measures." The present research direction of HIV-KS is focused on exploring the emerging prevalence, diagnostic methods, and therapeutics. Conclusion: This study outlines the current landscape and emerging hotspots of HIV-KS research, offering insights into thematic evolution and collaboration patterns. By identifying key research priorities and structural gaps, the findings can inform future scientific directions, guide resource allocation, and support more context-sensitive strategies for the diagnosis, treatment, and prevention of HIV-KS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.